NCT01555788View on ClinicalTrials.gov

DiaPort Closed-Loop Artificial Pancreas

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions
Type 1 Diabetes Mellitus
Interventions
DEVICE

Artificial Pancreas for DiaPort system with Zone-MPC algorithm

Artificial pancreas system uses the intraperitoneal route to deliver insulin (through DiaPort) in type 1 diabetic patients treated by basal-bolus insulin and external pumps.

Trial Locations (1)

34000

Montpellier University Hospital, Montpellier

All Listed Sponsors
lead

University Hospital, Montpellier

OTHER

NCT01555788 - DiaPort Closed-Loop Artificial Pancreas | Biotech Hunter | Biotech Hunter